USD726899SActiveUtility

Chewable dosage form

52
Assignee: Aspire PharmaceuticalsPriority: Jul 22, 2013Filed: Jul 22, 2013Granted: Apr 14, 2015
Est. expiryJul 22, 2033(~7 yrs left)· nominal 20-yr term from priority
52
PatentIndex Score
11
Cited by
10
References
1
Claims

Claims

exact text as granted — not AI-modified
CLAIM 
     
       The ornamental design for a chewable dosage form, as shown and described.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.